BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oncology News, Insights, Stories by OncoDaily - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Oncology News, Insights, Stories by OncoDaily
X-ORIGINAL-URL:https://oncodaily.com
X-WR-CALDESC:Events for Oncology News, Insights, Stories by OncoDaily
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20240310T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20241103T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20260308T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20261101T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20270314T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20271107T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Copenhagen
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Madrid
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Zurich
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260401
DTEND;VALUE=DATE:20260402
DTSTAMP:20260405T015506
CREATED:20251228T201317Z
LAST-MODIFIED:20251228T201327Z
UID:10000541-1775001600-1775087999@oncodaily.com
SUMMARY:ESMO Deep Dive: Genitourinary Cancers: Renal Cell Carcinoma Frontiers: Innovative Therapies and Precision Diagnostics 2026
DESCRIPTION:The ESMO Deep Dive: Genitourinary Cancers: Renal Cell Carcinoma Frontiers: Innovative Therapies and Precision Diagnostics 2026 webinar\, scheduled for April 1\, 2026\, focuses on the integration of precision diagnostics and innovative therapies in the management of Renal Cell Carcinoma (RCC). \nChaired by Viktor Gruenwald\, the program addresses the clinical challenges of treatment sequencing and patient selection in a rapidly evolving therapeutic landscape. Key sessions cover molecular tailoring for treatment stratification\, the emergence of molecular imaging as a diagnostic and therapeutic tool\, and evidence-based strategies for second-line management of metastatic RCC. \nRegister.
URL:https://oncodaily.com/event/esmo-deep-dive-435270
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ESMO-on-Air.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260327
DTEND;VALUE=DATE:20260329
DTSTAMP:20260405T015506
CREATED:20251228T200812Z
LAST-MODIFIED:20251228T200821Z
UID:10000540-1774569600-1774742399@oncodaily.com
SUMMARY:ESMO Advanced Course on the Evolving Role of CDK4/6 Inhibitors in Hormone Receptor Positive HER2 Negative Early and Advanced Breast Cancer 2026: Beijing
DESCRIPTION:The ESMO Advanced Course on the Evolving Role of CDK4/6 Inhibitors in Hormone Receptor Positive HER2 Negative Early and Advanced Breast Cancer 2026: Beijing is an intensive educational symposium scheduled for March 27–28\, 2026\, in Beijing\, China. \nCo-chaired by Giuseppe Curigliano and Binghe Xu\, this 1.5-day course is specifically designed for experienced oncologists and oncology specialists to deepen their understanding of CDK4/6 inhibition in both early and metastatic HR+/HER2- breast cancer settings. The course is accredited with 11 ESMO-MORA category 1 points\, serving as a vital platform for clinicians in the Asia-Pacific region to integrate the latest evidence into precision breast cancer management. \nApplication.
URL:https://oncodaily.com/event/esmo-advanced-course-435266
LOCATION:Beijing\, China
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ESMO-3.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Copenhagen:20260325T080000
DTEND;TZID=Europe/Copenhagen:20260328T170000
DTSTAMP:20260405T015506
CREATED:20250712T062245Z
LAST-MODIFIED:20250712T062307Z
UID:10000211-1774425600-1774717200@oncodaily.com
SUMMARY:The European Lung Cancer Congress (ELCC 2026)
DESCRIPTION:The European Lung Cancer Congress (ELCC 2026) will take place from 25–28 March 2026 in Copenhagen\, Denmark\, bringing together leading multidisciplinary societies dedicated to thoracic oncology. This congress serves as a key platform for advancing science\, sharing education\, and enhancing lung cancer care practices globally. \nWith a comprehensive programme designed for medical oncologists\, radiation oncologists\, thoracic surgeons\, respiratory physicians\, interventional radiologists\, and pathologists\, ELCC 2026 offers valuable learning and networking opportunities. Participants are invited to engage in interactive sessions and connect with lung cancer specialists from around the world.
URL:https://oncodaily.com/event/elcc-2026-327158
LOCATION:Bella Center\, Center Boulevard 5\, Copenhagen\, 2300\, Denmark
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/07/IMG_7077.jpg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260325
DTEND;VALUE=DATE:20260326
DTSTAMP:20260405T015506
CREATED:20251228T200222Z
LAST-MODIFIED:20251228T200236Z
UID:10000539-1774396800-1774483199@oncodaily.com
SUMMARY:ESMO Guidelines: Real World Cases - Webinar Series: Endometrial Cancer 2026
DESCRIPTION:The ESMO Guidelines: Real World Cases – Webinar Series: Endometrial Cancer 2026 is a specialized virtual scientific meeting scheduled for March 25\, 2026\, focused on the practical application of clinical practice guidelines in the management of endometrial cancer. \nChaired by Ana Oaknin\, the webinar features a multidisciplinary panel of experts who discuss the diagnosis\, staging\, and therapeutic sequencing for endometrial malignancies through the lens of a real-world clinical case. The session provides oncology professionals with 1 ESMO-MORA category 1 point and serves as a forum for translating the latest ESMO Clinical Practice Guidelines into individualized patient care. \nRegister.
URL:https://oncodaily.com/event/esmo-guidelines-435260
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ESMO-on-Air-1-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20260319T080000
DTEND;TZID=Europe/Madrid:20260321T170000
DTSTAMP:20260405T015506
CREATED:20250719T103826Z
LAST-MODIFIED:20250801T203138Z
UID:10000223-1773907200-1774112400@oncodaily.com
SUMMARY:The ICHNO 2026
DESCRIPTION:The ICHNO 2026\, the 10th International Congress on Innovative Approaches in Head and Neck Oncology\, will be held from 19–21 March 2026 in Seville\, Spain\, under the theme: “Driven by Biology\, Centred on the Person.”  \nThis unique event—jointly organized by ESTRO\, EHNS\, and ESMO—will bring together the full spectrum of multidisciplinary expertise to explore the latest advances in head and neck oncology\, grounded in biology and focused on the individual. \nWith global thought leaders\, impactful research\, and opportunities for meaningful dialogue\, ICHNO 2026 will be a vital platform for education\, exchange\, and collaboration. The Chairpersons of the 10th ICHNO Congress are Mererid Evans (ESTRO)\, Giovanni Succo (EHNS)\, and Yungan Tao (ESMO). \nMore posts featuring European Society for Radiotherapy and Oncology on OncoDaily.
URL:https://oncodaily.com/event/the-ichno-2026-332267
LOCATION:Fibes – Conference and Exhibition\, Ave. Alcalde Luis Uruñuela\, 1\, Seville\, 41020\, Spain
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/08/IMG_7601.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260316
DTEND;VALUE=DATE:20260319
DTSTAMP:20260405T015506
CREATED:20251114T213627Z
LAST-MODIFIED:20251114T213641Z
UID:10000355-1773619200-1773878399@oncodaily.com
SUMMARY:ESMO Targeted Anticancer Therapies Congress 2026
DESCRIPTION:The ESMO Targeted Anticancer Therapies (TAT) Congress 2026 is a major scientific forum organized by the European Society for Medical Oncology (ESMO)\, focused on accelerating the delivery of life-changing anticancer therapies through early drug development. \nThe congress will be held from March 16 to 18\, 2026\, at the Palais des Congrès in Paris\, France. The event serves as a dynamic\, multi-stakeholder meeting\, uniting researchers\, industry leaders\, investors\, and regulators to share new data\, foster collaboration\, and tackle the challenges of advancing early clinical development in oncology. \nElena Garralda\, Carlos Gomez-Roca\, and Cristian Massacesi serve as the co-chairs.
URL:https://oncodaily.com/event/esmo-409793
LOCATION:Palais des Congrès de Paris\, 2 Pl de la Pte Maillot\, Paris\, Île-de-France\, 75017\, France
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/07/IMG_7078.jpg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Zurich:20260312T080000
DTEND;TZID=Europe/Zurich:20260314T170000
DTSTAMP:20260405T015506
CREATED:20250710T195346Z
LAST-MODIFIED:20250710T195614Z
UID:10000209-1773302400-1773507600@oncodaily.com
SUMMARY:The ESMO Sarcoma and Rare Cancers Congress 2026
DESCRIPTION:The ESMO Sarcoma and Rare Cancers Congress 2026 will take place from 12–14 March in Lugano\, Switzerland\, offering a premier platform for experts to share cutting-edge research and innovative treatment approaches in rare solid tumours. \nThe congress will discuss the latest developments in diagnosis\, treatment\, molecular biology\, and classification of sarcomas and other rare cancers. The programme includes a wide range of sessions such as abstract presentations\, educational lectures\, multidisciplinary tumour boards\, guidelines updates\, and dedicated discussions for young oncologists. With opportunities for clinicians\, researchers\, industry professionals\, and patient advocates to connect and collaborate\, the congress promises three days of enriching scientific exchange and community building in the field of rare cancers.
URL:https://oncodaily.com/event/esmo-326996
LOCATION:“Palazzo dei Congressi” in Lugano\, Switzerland\, Piazza Indipendenza 4\, Lugano\, 6900\, Switzerland
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/07/IMG_7057.jpg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260311
DTEND;VALUE=DATE:20260314
DTSTAMP:20260405T015506
CREATED:20251126T122443Z
LAST-MODIFIED:20251126T122508Z
UID:10000407-1773187200-1773446399@oncodaily.com
SUMMARY:ESMO - The Christie Preceptorship on Lung Cancer 2026: Manchester
DESCRIPTION:The ESMO – The Christie Preceptorship on Lung Cancer 2026: Manchester will be held from March 11-13\, 2026\, in Manchester\, United Kingdom. \nThe application deadline is January 21\, 2026\, at 23:59 CET\, and the course is accredited for 16 ESMO-MORA category 1 points. \nThe learning objectives cover the full spectrum of thoracic oncology\, from screening and management of early-stage non-small cell lung cancer (NSCLC) to multi-modality treatment for locally advanced disease and systemic therapy for mesothelioma and small-cell lung cancer (SCLC)\, with a focus on advanced treatments like targeted agents for actionable driver mutations\, novel immunotherapies\, and palliative care. \nApply.
URL:https://oncodaily.com/event/esmo-the-christie-preceptorship416745
LOCATION:Manchester\, United Kingdom
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/ESMO-Christie.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260306
DTEND;VALUE=DATE:20260308
DTSTAMP:20260405T015506
CREATED:20251221T215815Z
LAST-MODIFIED:20251221T215832Z
UID:10000517-1772755200-1772927999@oncodaily.com
SUMMARY:ESMO Advanced Course on Management of Patients with Localised Bladder Cancer: State-of-the-Art Therapeutic Strategies and Ongoing Research 2026: Zurich
DESCRIPTION:The ESMO Advanced Course on Management of Patients with Localised Bladder Cancer: State-of-the-Art Therapeutic Strategies and Ongoing Research 2026: Zurich is an intensive educational program designed to provide medical oncologists with a comprehensive update on state-of-the-art therapeutic strategies and ongoing research. \nScheduled for March 6–7\, 2026\, in Zurich\, Switzerland\, the course focuses on multidisciplinary care\, evidence-based management\, and the interpretation of novel translational research\, including molecular profiling and clinical trials. \nLed by co-chairs Viktor Gruenwald and Bernadett Szabados\, the program offers successful applicants complimentary registration\, accommodation\, and a travel grant\, emphasizing ESMO’s commitment to advancing professional expertise in bladder cancer treatment. \nApplication.
URL:https://oncodaily.com/event/esmo-432406
LOCATION:Zurich\, Switzerland
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ESMO.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260304
DTEND;VALUE=DATE:20260306
DTSTAMP:20260405T015506
CREATED:20251126T003017Z
LAST-MODIFIED:20251126T003058Z
UID:10000405-1772582400-1772755199@oncodaily.com
SUMMARY:ESMO Advanced Course on Precision Medicine for Patients with HR+ HER2- Advanced Breast Cancer: Testing\, Selecting\, Treating 2026: Zurich
DESCRIPTION:The ESMO Advanced Course on Precision Medicine for Patients with HR+ HER2- Advanced Breast Cancer: Testing\, Selecting\, Treating 2026: Zurich is a two-day course for experienced oncologists and specialists\, focusing on using precision medicine to manage patients with HR-positive\, HER2-negative metastatic breast cancer. \nThe event is scheduled to take place on March 4–5\, 2026\, in Zurich\, Switzerland. \nThe application deadline for participation is January 7\, 2026\, at 23:59 CET. The course objectives include understanding the rationale and technical background of biomarker testing\, using results for optimal patient selection\, and discussing the proactive management of precision-medicine-based treatments. \nApply.
URL:https://oncodaily.com/event/breast-cancer-416477
LOCATION:Zurich\, Switzerland
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/esmo-2-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260304
DTEND;VALUE=DATE:20260305
DTSTAMP:20260405T015506
CREATED:20251227T145828Z
LAST-MODIFIED:20251227T145837Z
UID:10000538-1772582400-1772668799@oncodaily.com
SUMMARY:ESMO Deep Dive: Genitourinary Cancers : Beyond Cure: Optimizing Medical Care in Metastatic Bladder Cancer 2026
DESCRIPTION:The ESMO Deep Dive: Genitourinary Cancers: Beyond Cure: Optimizing Medical Care in Metastatic Bladder Cancer 2026 is a specialized scientific webinar designed to provide an in-depth clinical analysis of the treatment landscape for metastatic urothelial carcinoma (mUC). \nScheduled for March 4\, 2026\, this virtual session focuses on the technical challenges of managing advanced disease where cure is no longer the primary objective\, emphasizing the optimization of medical care through personalized treatment sequencing. This educational event\, chaired by Michiel S. van der Heijden\, is part of the ESMO Deep Dive series\, which utilizes evidence-based data and expert-led discussion to refine clinical decision-making for complex genitourinary oncological cases. \nRegister.
URL:https://oncodaily.com/event/esmo-deep-dive-434709
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ESMO-Deep-Dive.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260225
DTEND;VALUE=DATE:20260226
DTSTAMP:20260405T015506
CREATED:20251126T002352Z
LAST-MODIFIED:20251126T002404Z
UID:10000404-1771977600-1772063999@oncodaily.com
SUMMARY:ESMO Guidelines: Real World Cases - Webinar Series: Gastroesophageal Cancer 2026
DESCRIPTION:The ESMO Guidelines: Real World Cases – Webinar Series: Gastroesophageal Cancer 2026 is a virtual event designed to help medical professionals apply the latest ESMO Clinical Practice Guidelines to the complex management of gastroesophageal cancers using real-world clinical cases. \nThe webinar will be broadcast live virtually on February 25\, 2026\, at 18:30 CET. The discussion will focus on the complexities and evolving areas of practice\, such as optimal biomarker testing\, the integration of immunotherapy\, and the management of treatment-related toxicities. \nRegister.
URL:https://oncodaily.com/event/esmo-guidelines-416474
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/11/esmo.jpg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260218
DTEND;VALUE=DATE:20260220
DTSTAMP:20260405T015506
CREATED:20251126T002120Z
LAST-MODIFIED:20251126T002132Z
UID:10000403-1771372800-1771545599@oncodaily.com
SUMMARY:ESMO Preceptorship on Metastatic Bladder and Kidney Cancer 2026: Lugano
DESCRIPTION:The ESMO Preceptorship on Metastatic Bladder and Kidney Cancer 2026: Lugano is a two-day educational course focusing on the management of metastatic bladder and kidney cancer\, providing oncologists with a thorough understanding of current standards of care\, molecular pathology\, and novel treatment targets. \nThe preceptorship will take place on February 18–19\, 2026\, in Lugano\, Switzerland\, and is accredited with ESMO-MORA category 1 points. Successful applicants receive complimentary course registration and accommodation. The application deadline for this event is December 11\, 2025. \nApply.
URL:https://oncodaily.com/event/esmo-preceptorship-416470
LOCATION:Lugano\, Switzerland
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/esmo-1-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260218
DTEND;VALUE=DATE:20260219
DTSTAMP:20260405T015506
CREATED:20251227T145119Z
LAST-MODIFIED:20251227T145133Z
UID:10000537-1771372800-1771459199@oncodaily.com
SUMMARY:ESMO Therapeutic Landscapes: Toxicity of Multispecific Antibodies and Immune-Cell Engagers 2026
DESCRIPTION:ESMO Therapeutic Landscapes: Toxicity of Multispecific Antibodies and Immune-Cell Engagers 2026 is a specialized technical webinar scheduled for February 18\, 2026\, focused on the safety profiles and clinical management of next-generation biologics. \nChaired by Elena Garralda\, the program features expert discussions on the molecular mechanisms of on-target/off-tumor effects and evaluates emerging mitigation strategies to optimize patient outcomes. This virtual event\, part of the ESMO Therapeutic Landscapes series\, provides attendees with 1 ESMO-MORA category 1 point and serves as a vital forum for clinicians to refine their expertise in navigating the complexities of modern immunotherapy toxicity. \nRegister.
URL:https://oncodaily.com/event/esmo-therapeutic-landscapes-434705
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ESMO-Therapeutic-Landscapes.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260212
DTEND;VALUE=DATE:20260214
DTSTAMP:20260405T015506
CREATED:20260128T214419Z
LAST-MODIFIED:20260128T214424Z
UID:10000641-1770854400-1771027199@oncodaily.com
SUMMARY:1st Best of ESMO Levant
DESCRIPTION:The 1st Best of ESMO Levant is scheduled to take place on February 12–13\, 2026\, in Sulaymaniyah\, Iraq. \nOrganized by the Iraqi Society of Clinical Oncology (ISCO) in collaboration with ESMO\, this landmark regional conference is designed to bring the most critical clinical updates and practice-changing research from recent ESMO congresses to the Levant region. \nThe event provides a vital platform for local and international oncology experts to discuss the integration of global standards into regional clinical practice\, focusing on enhancing cancer care delivery through education\, research\, and collaborative innovation.
URL:https://oncodaily.com/event/best-of-esmo-levant-448598
LOCATION:Grand Millennium Hotel Sulaimani\, Sulaymaniyah\, Sulaymaniyah Governorate\, Sulaymaniyah\, 46001\, Iraq
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/ESMO-11.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260211
DTEND;VALUE=DATE:20260212
DTSTAMP:20260405T015506
CREATED:20251126T120522Z
LAST-MODIFIED:20251126T120536Z
UID:10000406-1770768000-1770854399@oncodaily.com
SUMMARY:RWD and Digital Oncology: EBAI Framework: Evaluating AI-Based Biomarkers in Oncology 2026
DESCRIPTION:The Real World Data and Digital Oncology webinar\, EBAI Framework: Evaluating AI-Based Biomarkers in Oncology 2026\, is a virtual event that focuses on the practical application of the ESMO Basic Requirements for AI-based Biomarkers in Oncology (EBAI) framework. \nThe live broadcast date is 11 February 2026 at 18:30 CET. This session will explore how emerging AI-driven biomarkers can be effectively assessed\, validated\, and integrated into clinical decision-making. \nRegister.
URL:https://oncodaily.com/event/digital-oncology-416739
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/ESMO-1-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20260209T140000
DTEND;TZID=Europe/Paris:20260209T150000
DTSTAMP:20260405T015506
CREATED:20260126T010719Z
LAST-MODIFIED:20260126T010728Z
UID:10000623-1770645600-1770649200@oncodaily.com
SUMMARY:Pregnancy-Associated Cancer: Clinical Challenges and Ethical Insights
DESCRIPTION:The ESMO Young Oncologists Committee (YOC) will host the next session of the YO4YO Virtual Session Series on Monday\, February 9\, 2026\, from 14:00 to 15:00 CET. This interactive Clinical Case Discussion\, titled “Pregnancy-associated cancer: Clinical challenges and ethical insights\,” is designed to provide young oncologists with a platform to engage with experts on complex clinical scenarios and their associated ethical dilemmas. \nThe session features a distinguished panel\, including Guilherme Nader Marta as the YOC Coordinator\, alongside experts Ann Partridge and Matteo Lambertini\, who will lead the dialogue and offer practical guidance for managing these challenging cases. These virtual sessions aim to foster international collaboration and networking among early-career oncology professionals while addressing specific professional and scientific development needs. \nJoin the session.
URL:https://oncodaily.com/event/pregnancy-associated-cancer-447025
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/ESMO-6.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:https://esmo-org.zoom.us/j/87294357860?pwd=IHPJamhrV2Ukauh0paWbNjgPrNFKJe.1#success
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260206
DTEND;VALUE=DATE:20260209
DTSTAMP:20260405T015506
CREATED:20251102T222927Z
LAST-MODIFIED:20251102T222940Z
UID:10000311-1770336000-1770595199@oncodaily.com
SUMMARY:ESMO Summit Africa 2026
DESCRIPTION:The ESMO Summit Africa 2026 is a three-day educational event focused on delivering a summary and contextual review of the most significant cancer treatment advances presented at the previous ESMO annual Congress\, tailored specifically for the oncology community in Africa. Scheduled to take place in Cape Town\, South Africa\, from 6 to 8 February 2026\, the Summit’s main objectives are to review the current standard of care for key malignancies from both a local and international perspective and to discuss current controversies in cancer management. \nYou can find more posts featuring ESMO on OncoDaily.
URL:https://oncodaily.com/event/esmo-summit-africa-402240
LOCATION:Century City Conference Centre\, 4 Energy Lane\, Century City\, Cape Town\, Western Cape\, 7446\, South Africa
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2025/11/ESMO-Africa.png
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260205
DTEND;VALUE=DATE:20260207
DTSTAMP:20260405T015506
CREATED:20251126T001629Z
LAST-MODIFIED:20251126T001641Z
UID:10000402-1770249600-1770422399@oncodaily.com
SUMMARY:ESMO Preceptorship on Cervical Cancer 2026: Cape Town
DESCRIPTION:The ESMO Preceptorship on Cervical Cancer 2026: Cape Town is a two-day educational course focusing on providing oncologists with a thorough understanding of cervical cancer management\, including screening\, prevention\, diagnosis\, and the standard of care for early\, locally advanced\, recurrent\, and metastatic disease. The event is scheduled for February 5–6\, 2026\, in Cape Town\, South Africa\, and is accredited with ESMO-MORA category 1 points.
URL:https://oncodaily.com/event/esmo-preceptorship-416466
LOCATION:Cape Town\, South Africa
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/ESMO-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260204
DTEND;VALUE=DATE:20260205
DTSTAMP:20260405T015506
CREATED:20251227T144458Z
LAST-MODIFIED:20251227T144507Z
UID:10000536-1770163200-1770249599@oncodaily.com
SUMMARY:ESMO Deep Dive: Genitourinary cancers: Multimodal Therapy in MIBC: From Established Standard to Future Directions 2026
DESCRIPTION:The ESMO Deep Dive: Genitourinary Cancers: Multimodal Therapy in MIBC: From Established Standard to Future Directions 2026 is a technical scientific webinar focused on the evolving treatment landscape of muscle-invasive bladder cancer (MIBC). Scheduled for February 4\, 2026\, this virtual symposium addresses the clinical challenges of MIBC\, which is characterized by high morbidity and mortality. \nOrganized by the European Society for Medical Oncology (ESMO) and chaired by Viktor Gruenwald\, the webinar aims to equip oncology professionals with the skills to critically evaluate emerging data and personalize therapeutic approaches\, including bladder-sparing modalities and biomarker-enabled precision medicine. \nRegister.
URL:https://oncodaily.com/event/esmo-deep-dive-434701
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ESMO-on-Air-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260131
DTEND;VALUE=DATE:20260201
DTSTAMP:20260405T015506
CREATED:20251227T143844Z
LAST-MODIFIED:20251227T143852Z
UID:10000535-1769817600-1769903999@oncodaily.com
SUMMARY:ESMO in Focus Immuno-Oncology Bulgaria 2026
DESCRIPTION:The ESMO in Focus Immuno-Oncology Bulgaria 2026 is a licensed scientific conference organized by the Bulgarian Scientific Society for Immuno-Oncology (BSIO) in collaboration with the European Society for Medical Oncology (ESMO). \nScheduled for January 31\, 2026\, in Sofia\, the meeting serves as a regional forum to disseminate the latest clinical data and therapeutic breakthroughs presented at the ESMO Immuno-Oncology Congress 2025 held in London. The technical program focuses on the evolution of personalized immunotherapy\, emerging biomarkers for checkpoint inhibitor response\, and the clinical management of immune-related adverse events across various solid tumors. \nRegister.
URL:https://oncodaily.com/event/esmo-in-focus-434690
LOCATION:InterContinental Sofia\, 4 Narodno Sabranie Square\, Sofia\, Sofia City\, 1000\, Bulgaria
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ESMO-Bulgaria.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260128
DTEND;VALUE=DATE:20260129
DTSTAMP:20260405T015506
CREATED:20251126T001040Z
LAST-MODIFIED:20251126T001052Z
UID:10000401-1769558400-1769644799@oncodaily.com
SUMMARY:ESMO Guidelines: Real World Cases - Webinar Series: Colorectal Cancer 2026
DESCRIPTION:The ESMO Guidelines: Real World Cases – Webinar Series: Colorectal Cancer 2026 is a live virtual event focused on discussing real-world clinical cases and applying ESMO guidelines to the management of colorectal cancer. This webinar is scheduled to take place virtually on January 28\, 2026\, at 18:30 CET (Central European Time). \nRegister.
URL:https://oncodaily.com/event/real-world-cases-416464
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/11/esmo.jpg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260124
DTEND;VALUE=DATE:20260125
DTSTAMP:20260405T015506
CREATED:20251227T142759Z
LAST-MODIFIED:20251227T142830Z
UID:10000534-1769212800-1769299199@oncodaily.com
SUMMARY:ESMO Advanced Course on CDK4/6 Inhibitors in Breast Cancer Management 2026: Jeddah
DESCRIPTION:The ESMO Advanced Course on CDK4/6 Inhibitors in Breast Cancer Management 2026 is an intensive\, single-day educational symposium scheduled for January 24\, 2026\, in Jeddah\, Saudi Arabia. \nOrganized by the European Society for Medical Oncology (ESMO)\, this event is designed as a closed course specifically for invited medical oncologists and oncology fellows from the Middle East. The program focuses on the biological function of CDK4/6 in breast cancer and the practical integration of CDK4/6 inhibitors into the treatment landscape for both early-stage and metastatic hormone receptor-positive (HR+) / HER2-negative breast cancer.
URL:https://oncodaily.com/event/breast-cancer-management-434682
LOCATION:Jeddah\, Saudi Arabia
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ESMO-2.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260121
DTEND;VALUE=DATE:20260122
DTSTAMP:20260405T015506
CREATED:20260120T144735Z
LAST-MODIFIED:20260120T144743Z
UID:10000602-1768953600-1769039999@oncodaily.com
SUMMARY:ESMO Therapeutic Landscapes: Toxicity of Cellular Therapies 2026
DESCRIPTION:The ESMO webinar “Therapeutic Landscapes: Toxicity of Cellular Therapies 2026“ is a specialized virtual educational session scheduled for January 21\, 2026\, at 18:30 CET. \nLed by chairs and speakers Claire Roddie\, Marco Donia\, and Changsong Qi\, the program focuses on the recognition and management of unique complications arising from advanced cancer treatments\, specifically CAR-T and TIL-based adoptive cell therapies. Key topics include the clinical presentation of cytokine release syndrome (CRS)\, immune effector cell-associated neurotoxicity syndrome (ICANS)\, and emerging toxicities associated with tumor-infiltrating lymphocytes. \nRegister.
URL:https://oncodaily.com/event/toxicity-of-cellular-therapies-444070
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/ESMO-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260116
DTEND;VALUE=DATE:20260118
DTSTAMP:20260405T015506
CREATED:20251124T213453Z
LAST-MODIFIED:20251124T213510Z
UID:10000400-1768521600-1768694399@oncodaily.com
SUMMARY:ESMO Preceptorship on Breast Cancer 2026: Milan
DESCRIPTION:The ESMO Preceptorship on Breast Cancer 2026: Milan is a two-day educational course that provides oncologists with a thorough understanding of breast cancer management\, covering topics from diagnosis to treatment\, based on current standards of care in a multidisciplinary setting. \nThe preceptorship will take place from January 16–17\, 2026\, in Milan\, Italy. The course is accredited with ESMO-MORA category 1 points\, and the application deadline for attendance is November 25\, 2025. \nApply.
URL:https://oncodaily.com/event/preceptorship-on-breast-cancer-415828
LOCATION:Milan\, Italy
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/16_9-2.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251216
DTEND;VALUE=DATE:20251218
DTSTAMP:20260405T015506
CREATED:20251124T213007Z
LAST-MODIFIED:20251124T213103Z
UID:10000399-1765843200-1766015999@oncodaily.com
SUMMARY:ESMO Preceptorship on Prostate Cancer 2025: Lugano
DESCRIPTION:The ESMO Preceptorship on Prostate Cancer 2025: Lugano is a two-day educational course focusing on a thorough understanding of prostate cancer management\, from diagnosis to treatment\, according to current standards of care. \nOrganized by the European Society for Medical Oncology (ESMO)\, the event is scheduled to take place on December 16–17\, 2025\, in Lugano\, Switzerland. The preceptorship is designed primarily for medical and clinical oncologists\, especially young oncologists\, and has been accredited for 9 ESMO-MORA category 1 points.
URL:https://oncodaily.com/event/preceptorship-on-prostate-cancer-415823
LOCATION:Lugano\, Switzerland
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/09/1756803627507.jpeg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251213
DTEND;VALUE=DATE:20251215
DTSTAMP:20260405T015506
CREATED:20251124T212249Z
LAST-MODIFIED:20251124T212304Z
UID:10000398-1765584000-1765756799@oncodaily.com
SUMMARY:Best of ESMO India 2025
DESCRIPTION:The Best of ESMO India 2025 is an ESMO-licensed event making its Indian debut in Mumbai\, scheduled for December 13–14\, 2025. \nThis conference\, hosted by the Global Healthcare Academy (GHA)\, is a major platform for disseminating the most recent\, cutting-edge data and clinical practices from the main European Society for Medical Oncology (ESMO) Congress. \nDesigned for a multidisciplinary audience including medical\, surgical\, and radiation oncologists\, the event will feature focus sessions guided by an extensive advisory\, core\, and scientific committee comprising leading Indian oncologists\, and will be held at The St. Regis Mumbai. \nRegister.
URL:https://oncodaily.com/event/best-of-esmo-india-415818
LOCATION:The St. Regis Mumbai\, 462 Senapati Bapat Marg\, Lower Parel\, Mumbai\, Maharashtra\, 400013\, India
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/16_9-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20251210T083000
DTEND;TZID=America/Halifax:20251210T120000
DTSTAMP:20260405T015506
CREATED:20251206T001840Z
LAST-MODIFIED:20251206T001927Z
UID:10000455-1765355400-1765368000@oncodaily.com
SUMMARY:ESMO-IO SITC Primer Program
DESCRIPTION:The ESMO-IO SITC Primer Program is a joint educational event organized by the European Society for Medical Oncology (ESMO) and the Society for Immunotherapy of Cancer (SITC)\, scheduled for December 10\, 2025\, from 8:30 a.m. to 12:00 p.m. BST. \nThis half-day primer\, held at the Queen Elizabeth II Centre in London\, UK\, focuses on fundamental immuno-oncology (IO) concepts. \nThe program will cover current and emerging topics in immuno-oncology (IO)\, including neoadjuvant immunotherapy\, intratumoral immunotherapies\, recombinant cytokines\, and bispecific antibodies\, alongside new applications of AI\, spatial biology\, and multiomic approaches.
URL:https://oncodaily.com/event/esmo-422513
LOCATION:Queen Elizabeth II Centre in London\, United Kingdom\, Broad Sanctuary\, London SW1P 3EE\, London\, United Kingdom
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ESMOSITC.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251210T080000
DTEND;TZID=Europe/London:20251212T170000
DTSTAMP:20260405T015506
CREATED:20250701T130014Z
LAST-MODIFIED:20250701T130110Z
UID:10000206-1765353600-1765558800@oncodaily.com
SUMMARY:ESMO Immuno-Oncology Congress 2025
DESCRIPTION:The ESMO Immuno-Oncology Congress 2025 will be held from 10 to 12 December 2025 as a hybrid event\, both onsite in London\, UK\, and online. This leading international congress brings together experts from around the globe to explore the full spectrum of immuno-oncology from basic science and translational research to clinical advancements. Attendees can expect cutting-edge sessions\, in-depth learning opportunities\, and dynamic networking with peers\, researchers\, and industry leaders. \nThe programme includes immersion sessions focused on immunobiology and translational insights\, updates on checkpoint inhibitor-based therapies\, and the latest in immune modulation including tumour microenvironment\, immunometabolism\, and cell signaling. Participants will also engage with industry and independent investigators to explore developments in cellular therapies\, cancer vaccines\, intratumoural immunotherapy\, and multispecific constructs. \nWhether attending in person or online\, the congress offers a valuable platform to share research\, expand knowledge\, and shape the future of cancer immunotherapy. \nRegistration is Open for the Event. \nMore posts featuring ESMO.
URL:https://oncodaily.com/event/esmo-immuno-oncology-congress-2025-321830
LOCATION:Queen Elizabeth II Centre in London\, United Kingdom\, Broad Sanctuary\, London SW1P 3EE\, London\, United Kingdom
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/07/IMG_6227.jpg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251210
DTEND;VALUE=DATE:20251211
DTSTAMP:20260405T015506
CREATED:20251123T193232Z
LAST-MODIFIED:20251123T193250Z
UID:10000395-1765324800-1765411199@oncodaily.com
SUMMARY:ESMO Virtual Journal Club: December 2025
DESCRIPTION:The ESMO Virtual Journal Club: December 2025 is a one-hour virtual educational event exclusively for ESMO Members\, scheduled for Wednesday\, December 10\, 2025\, at 18:30 CET. \nChaired by Dr. Anna Campbell\, the Journal Club aims to enhance the understanding and application of the latest research in oncology by focusing on and critically evaluating two newly published studies: “Structured Exercise after Adjuvant Chemotherapy in Colon Cancer (CHALLENGE)” and “Low-Dose Aspirin for PI3K-Altered Localized Colorectal Cancer.” Live attendees will receive a certificate of attendance and 1 ESMO-MORA category 1 point. \nRegister.
URL:https://oncodaily.com/event/esmo-virtual-journal-club-415070
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2025/11/ESMO-1-1.png
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:
END:VEVENT
END:VCALENDAR